Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Leslie O'Neill Reising"'
Autor:
Timothy R. Holzer, Sameera R. Wijayawardana, Gerard J. Oakley, Narasimha Marella, Holly Kay Cannon, Jessica A. Roseberry Baker, Anthony N. Sireci, Juraj Bodo, Joel D. Cook, Tyler J Marquart, Andrew E. Schade, Eric D. Hsi, Leslie O'Neill Reising
Publikováno v:
Archives of Pathology & Laboratory Medicine. 146:351-359
Context.— RET gene fusions are oncogenic drivers in nonsmall cell lung cancer and nonmedullary thyroid cancer. Selpercatinib (RETEVMO), a targeted inhibitor of RET, was approved by the US Food and Drug Administration for the treatment of RET fusion
Autor:
Aaron M Gruver, Timothy R. Holzer, Bradley L. Ackermann, Daniel C. Liebler, Andrew E. Schade, Ryan D. Morrison, Jeff A. Fill, Leslie O'Neill Reising, Alexander Haragan
Publikováno v:
Scientific Reports
Scientific Reports, Vol 10, Iss 1, Pp 1-10 (2020)
Scientific Reports, Vol 10, Iss 1, Pp 1-10 (2020)
New therapeutics targeting immune checkpoint proteins have significantly advanced treatment of non-small cell lung cancer (NSCLC), but protein level quantitation of drug targets presents a critical problem. We used multiplexed, targeted mass spectrom
Autor:
Gerard J. Oakley, Timothy R. Holzer, Leslie O'Neill Reising, Andrew E. Schade, Kelly M. Credille
Publikováno v:
Journal of Histochemistry & Cytochemistry. 64:785-810
Aberrant regulation of the receptor tyrosine kinase platelet-derived growth factor alpha (PDGFRα) is implicated in several types of cancer. Inhibition of the PDGFRα pathway may be a beneficial therapy, and detection of PDGFRα in tumor biopsies may
Autor:
Timothy R, Holzer, Angie D, Fulford, Leslie O'Neill, Reising, Drew M, Nedderman, Xuekui, Zhang, Laura E, Benjamin, Andrew E, Schade, Aejaz, Nasir
Publikováno v:
Anticancer research. 36(7)
the vascular endothelial growth factor (VEGF) pathway plays a prominent role in the growth and progression of human cancer, including non-small cell lung carcinoma (NSCLC). The key mediators of VEGF signaling are a family of related receptor tyrosine
Autor:
Aejaz, Nasir, Leslie O'Neill, Reising, Drew M, Nedderman, Angie D, Fulford, Mark T, Uhlik, Laura E, Benjamin, Andrew E, Schade, Timothy R, Holzer
Publikováno v:
Anticancer research. 36(6)
The vascular endothelial growth factor (VEGF) pathway plays an important role in growth and progression of human cancer, including colorectal carcinomas (CRC). The key mediators of VEGF signaling are VEGFR1, VEGFR2, and VEGFR3, part of a family of re
Autor:
Andrew E. Schade, Drew M. Nedderman, Leslie O'Neill Reising, Timothy R. Holzer, Aejaz Nasir, Laura E. Benjamin, Angie D. Fulford
Publikováno v:
Cancer Research. 75:4157-4157
The Vascular Endothelial Growth Factor (VEGF) pathway plays a prominent role in the growth and progression of human cancers, including non-small cell lung carcinoma (NSCLC). The key mediators of VEGF signaling are a family of related receptor tyrosin